ASCENTAGE PHARMA GROUP INTERNATIONAL
AAPG · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,181,536 | -$568,434 | $163,002 | -$523,286 |
| Dep. & Amort. | $0 | $45,858 | $47,312 | $47,620 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $26,096 | $12,194 | $8,730 | $13,254 |
| Change in WC | $0 | $87,360 | $0 | -$69,012 |
| Other Non-Cash | $1,155,440 | $666,056 | -$573,434 | $173,812 |
| Operating Cash Flow | $0 | $243,034 | -$354,390 | -$357,612 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$7,762 | -$16,526 | -$12,132 |
| Net Acquisitions | $0 | -$9,516 | $0 | -$20,000 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$213,478 | -$114,752 | $118,828 |
| Investing Cash Flow | $0 | -$230,756 | -$131,278 | $86,696 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$98,852 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$1,958 | -$5,922 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$82,138 | $497,716 | -$80,960 |
| Financing Cash Flow | $0 | -$82,138 | $396,906 | -$86,882 |
| Forex Effect | $0 | $10,528 | $3,150 | $5,858 |
| Net Chg. in Cash | $0 | $0 | $952,434 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $952,434 | $0 | $1,389,991 |
| End Cash | $0 | $893,100 | $952,434 | $1,038,048 |
| Free Cash Flow | $0 | $235,272 | -$370,916 | -$369,746 |